Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2020-01-23 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles, including executive, non-executive, and independent non-executive directors. It also details the composition of board committees such as the Audit Committee, Remuneration Committee, and Nomination Committee. There is no financial data, no mention of financial results, no voting results, no legal proceedings, and no report publication. The content is focused on board and management information, specifically the announcement of the board members and their committee roles. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report, so it is not RPA or RNS. Confidence is high due to clear and direct content about board composition.
2020-01-23 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHAIRPERSON OF THE AUDIT COMMITTEE AND REMUNERATION COMMITTEE
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of an independent non-executive director and chairperson of the audit and remuneration committees. It details the individual's background, roles, and terms of appointment. There is no financial data, no report attached or referenced as being published, and no mention of voting results or shareholder meetings. The content focuses on management changes at the board level. Therefore, this fits the category of Board/Management Information (MANG). The document length is moderate and contains detailed information about the director's appointment, consistent with a management announcement rather than a brief notice or regulatory filing.
2020-01-23 English
INSIDE INFORMATION UPDATE ON THE CONVERTIBLE BONDS
Capital/Financing Update Classification · 95% confidence The document is an announcement by Sinopharm Tech Holdings Limited regarding the status of its convertible bonds, including details about maturity, default events, and ongoing negotiations for renewal and refinancing. It references regulatory rules (GEM Listing Rules) and provides an update on a specific financing instrument. The document is relatively short (5163 characters) and serves as an update on capital structure and financing activities rather than a full financial report or audit. It does not contain financial statements or detailed financial analysis, nor is it a transcript, AGM material, or legal proceeding report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2020-01-19 English
GRANT OF SHARE OPTIONS
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the grant of share options to directors, chief executive, and employees of Sinopharm Tech Holdings Limited. It details the number of options granted, exercise price, validity period, and the recipients including directors and their associates. The announcement references compliance with the GEM Listing Rules and provides specific information about the share option scheme. This type of document is a notification about share option grants, which falls under capital or financing activities related to share-based compensation. It is not a full financial report, audit, or management discussion, nor is it a regulatory filing or voting result. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is about 4892 characters, which is sufficient for a detailed announcement rather than a brief notice or report publication announcement. Confidence is high given the clear content and context.
2020-01-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/12/2019. The content is focused on share capital changes and securities issuance, with no financial performance data or earnings information. It is a regulatory filing reporting monthly movements in securities rather than a financial report or announcement of voting results. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-01-06 English
PROPOSED ISSUE OF UNLISTED WARRANTS UNDER SPECIFIC MANDATE
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the proposed issue of unlisted warrants under a specific mandate by Sinopharm Tech Holdings Limited. It details the terms of the warrant subscription agreement, the number of warrants to be issued, the exercise price, the use of proceeds, and the conditions precedent for the issuance. The document is a formal announcement of a capital raising activity involving warrants, including details about the subscription agreement and shareholder approval requirements. It does not contain financial statements or quarterly results, nor is it a report or transcript. It is clearly an update on a financing activity, specifically the issuance of warrants as a capital raising measure. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2020-01-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.